S&P 500 Consumer Staples Sector SEC Filings — April 03, 2026

03-04-2026

The Morgan Stanley Bitcoin Trust, a Delaware statutory trust formed on December 16, 2025, filed an S-1/A registration statement on April 3, 2026, to register shares for public offering and listing on an exchange. The Trust delegates day-to-day operations to a Delaware-formed Delegated Sponsor (established September 19, 1980), with oversight from Cayman Trustee AGS Trustees Limited and DE Trustee CSC Delaware Trust Company; key service providers include The Bank of New York Mellon (Administrator, Transfer Agent, Cash Custodian, Bitcoin Custodian) and Coinbase Custody Trust Company, LLC (Bitcoin Custodian). The Trust incurs a unitary Delegated Sponsor Fee of 0.14% annualized on NAV, covering most operating expenses, with Bitcoin held in cold storage by custodians whose shared insurance may not fully cover losses.

• ·Trust Agreement amended and restated; Appleby Agreements dated March 25, 2026.
• ·Delegated Sponsor covers Sponsor-paid Expenses (e.g., custodian fees, audit, legal) from its fee; Additional Trust Expenses (e.g., taxes, litigation) paid separately from Bitcoin holdings.
• ·Bitcoin Custodians' insurance is shared, covers theft/fraud but not value loss or all risks, and is not FDIC-insured.

03-04-2026

Relmada Therapeutics, a clinical-stage biotech, filed an S-3 registration statement on April 3, 2026, to register for resale 33,685,096 shares of common stock issued in a $160.0 million private placement closed on March 11, 2026, consisting of 29,474,569 shares at $4.75 each and pre-funded warrants for 4,210,527 shares. The company terminated its prior lead programs, esmethadone (REL-1017) on July 7, 2025, and REL-P11 on May 12, 2025, following setbacks, but licensed NDV-01 (Phase 2 ongoing for NMIBC, Phase 3 expected mid-2026) and acquired sepranolone (Phase 2b-ready for PWS and others, study expected mid-2026). Proceeds from the private placement will support working capital, general corporate purposes, and advancement of these new product candidates.

• ·Pre-Funded Warrants exercisable at $0.001 per share, with beneficial ownership blockers at 9.99% or 4.99%.
• ·Private Placement shares priced at $4.75 per share and Pre-Funded Warrants at $4.749 each.
• ·Company qualifies as smaller reporting company with reduced disclosure obligations.
• ·Registration Rights Agreement requires filing by later of 45 days post-closing or one business day after 10-K filing on March 19, 2026.

03-04-2026

Ashford Inc. and Ashford Hospitality Advisors LLC notified Braemar Hotels & Resorts Inc. on March 31, 2026, of their election to extend the Fifth Amended and Restated Advisory Agreement (dated April 23, 2018) for an additional successive 10-year term, commencing January 24, 2027, and ending January 24, 2037, on the same terms and conditions. The extension is exercised pursuant to Section 12.2 of the agreement, subject to rights under Section 6.6, with prior Letter Agreements from August 26, 2025, and December 22, 2025, remaining in full force.

• ·Notice delivered via hand delivery and email at least 210 days prior to initial term expiration.
• ·Advisory Agreement initial term expires January 24, 2027.
• ·Extension right allows up to seven successive 10-year terms.

03-04-2026

Alta Equipment Group Inc. announced that its Board of Directors declared a dividend of $625 per share on its outstanding 10% Series A Cumulative Perpetual Preferred Stock, with a record date of April 15, 2026, and payment date of April 30, 2026. This dividend equates to $0.625 per Depositary Share (ALTG PRA) traded on the New York Stock Exchange. The press release detailing the announcement is filed as Exhibit 99.1.

03-04-2026

On March 30, 2026, Fidelity National Information Services, Inc. (FIS) was notified that Board Director Mark Benjamin will not stand for re-election at the 2026 annual meeting of shareholders, a decision not due to any disagreement with the Company's operations, policies, or practices. In connection with his departure, the Board approved reducing its size from ten to nine directors, effective immediately following the 2026 Shareholder Meeting. FIS's CEO Stephanie Ferris thanked Mr. Benjamin for his extraordinary contributions and dedication.

• ·Mr. Benjamin’s decision was not due to any disagreement with the Company on any matters relating to the Company’s operations, policies, or practices.

03-04-2026

Mondelez International, Inc. (MDLZ) filed DEFA14A Definitive Additional Proxy Soliciting Materials on April 03, 2026, as part of proxy statement activities ahead of a shareholder meeting. The document contains encoded proxy voting instructions and graphics but no discernible specific proposals or financial metrics. No period-over-period comparisons or performance data are present.

• ·Central Index Key: 0001103982
• ·Fiscal Year End: 1231
• ·State of Incorporation: IL
• ·Business Address: 905 West Fulton Market Street, Suite 200, Chicago, IL 60607

03-04-2026

Lyell Immunopharma, Inc. filed an S-3 registration statement on April 3, 2026, to register 1,952,360 shares of common stock for resale by selling stockholders, consisting of shares issued at the Milestone Closing of a July 24, 2025 private placement at $25.61 per share. The company will receive no proceeds from these resales and previously issued 3,753,752 shares at the Initial Closing at $13.32 per share. Selling stockholders include ARCH Venture Fund XIII, L.P., Euler Fund, L.P., Gates Frontier, LLC, and Explore Investments LLC, with post-offering beneficial ownership ranging from 4.0% to 11.8% based on 23,328,390 shares outstanding as of March 31, 2026.

• ·Selling stockholders have no current positions or offices with Lyell or affiliates, except historical board service by Robert Nelsen until May 2025.
• ·Company incorporated in June 2018; principal offices at 201 Haskins Way, South San Francisco, CA.
• ·Nasdaq symbol: LYEL.

03-04-2026

Krystal Biotech, Inc. (KRYS) filed a DEFA14A Definitive Additional Materials proxy statement (Schedule 14A) on April 03, 2026. The filing was made by the registrant with no fee required. No substantive financial or operational details are included in the provided filing content.

03-04-2026

On April 1, 2026, ClearOne, Inc. entered into a letter agreement with Derek L. Graham for his continued service as CEO on a transitional consulting basis after his prior employment agreement expired on March 31, 2026. Under the agreement, Mr. Graham will provide up to 10 hours per week of consulting services at $160 per hour while performing all CEO functions, with no fixed term and terminable by either party at any time. The full letter agreement is filed as Exhibit 10.1.

• ·Letter agreement filed as Exhibit 10.1
• ·Event reported date: April 3, 2026 (earliest event: April 1, 2026)

03-04-2026

Hennessy Capital Investment Corp. VII (HVII) filed an S-4/A registration statement on April 3, 2026, acting as a proxy statement/prospectus for its proposed business combination with ONE Nuclear Energy LLC via a merger agreement dated October 22, 2025, featuring a base purchase price of $1,000,000,000. The filing supports an extraordinary general meeting for shareholder approval of the transaction, domestication, and related proposals. No period-over-period financial performance data is provided in the filing excerpt.

• ·Business Combination Agreement dated October 22, 2025, between HVII, Merger Sub, and ONE Nuclear
• ·IPO referenced on January 21, 2025
• ·Proxy requests must be made by [date], 2026, or five business days prior to HVII Public Shareholders’ Meeting

03-04-2026

Mobix Labs, Inc. entered into a securities purchase agreement with Leviston Resources, LLC on March 31, 2026, issuing a senior secured convertible promissory note with $3,000,000 principal for $2,550,000 cash, representing a discount. The note carries 10% annual interest and matures on July 31, 2026, with conversion into common stock possible at a discounted price (85% of lowest 8-day VWAP or March 31 closing price), posing dilution risk. The company agreed to file a registration statement within 14 days for resale of conversion shares, to be effective within 30 days.

• ·Note maturity date: July 31, 2026
• ·Registration Statement filing deadline: no later than 14 days following March 31, 2026
• ·Registration Statement effectiveness deadline: no later than 30 days following March 31, 2026
• ·Issuance relies on Section 4(a)(2) and Rule 506(b) of Regulation D exemptions
• ·Exhibits to be filed in next Form 10-Q

03-04-2026

Situs Holdings, LLC was removed as special servicer for the Potomac Mills Mortgage Loan, which constitutes approximately 8.9% of the CFCRE 2016-C6 Mortgage Trust's asset pool as of the cut-off date, and Torchlight Loan Services, LLC was appointed as successor special servicer effective April 3, 2026, pursuant to the CFCRE 2016-C6 PSA. Torchlight has extensive experience, having resolved over $12.2 billion in U.S. commercial and multifamily loans since 1998 and managing a growing portfolio with named specially serviced UPB increasing from $6.68B as of 12/31/2022 to $18.36B as of 12/31/2025; however, its actively specially serviced portfolio UPB grew more modestly from $461.5M to $3.08B over the same period while personnel dedicated to special servicing remained limited at 4 out of 21 as of 12/31/2025.

• ·Change effective pursuant to Section 3.22(i) of the CFCRE 2016-C6 PSA dated November 1, 2016.
• ·Torchlight has no material primary advancing obligations and no known material legal proceedings.
• ·Torchlight is not an affiliate of key parties and owns no Certificates in the issuing entity.

03-04-2026

Mohawk Industries' 2026 Proxy Statement discloses 2025 non-employee director compensation totaling between $247,566 and $2,919,921 per director, with most receiving $100,000-$135,000 in cash fees and $147,566 in stock awards, while W. Christopher Wellborn's payout was driven by $2,919,921 in other compensation including LTIP awards and salary. KPMG LLP fees rose 7% YoY to $11,619,000 in 2025 from $10,852,000 in 2024, with audit fees increasing 9.9% to $11,333,000 but audit-related, tax, and other fees declining sharply by 39%, 47%, and 72% respectively. The filing includes proposals for ratifying KPMG as the 2026 independent auditor and an advisory vote on executive compensation.

• ·Non-employee directors with 5+ years tenure required to own shares worth 5x annual cash retainer.
• ·Restricted stock units granted January 2, 2025 vest in three equal annual installments.
• ·Bernard P. Thiers received prorated director comp from January 1 to May 22, 2025, plus Senior Executive LTIP for 2024 performance.
• ·W. Christopher Wellborn transitioned to senior advisor role February 1, 2025, with annualized base salary of $312,000.

03-04-2026

Harmony Biosciences Holdings, Inc. (HRMY) filed definitive additional proxy materials (DEFA14A) on April 3, 2026, for its 2026 Annual Meeting of Stockholders scheduled for May 14, 2026, at 1:00 p.m. ET virtually. Shareholders are to vote on: (1) election of four Class III directors (Geno J. Germano, Troy Ignelzi, Ron Philip, Andreas Wicki, Ph.D.) to serve until the 2029 annual meeting; (2) ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026; and (3) a non-binding advisory vote on named executive officer compensation.

• ·Voting deadline: May 13, 2026, 11:59 p.m. ET
• ·Virtual meeting URL: www.virtualshareholdermeeting.com/HRMY2026
• ·Proxy materials request deadline: April 30, 2026
• ·Control numbers referenced: V89931-P48489, V89932-P48489

03-04-2026

Elventix Technology Corp reported zero revenues and net losses of $31,820 for the three months ended February 28, 2026 and $68,189 for the nine months ended, with loss per share steady at $0.01 amid higher weighted average shares outstanding. While the company raised $38,925 via issuance of 1,297,500 common shares at $0.03 each and total assets grew 7.5% to $231,194, cash declined 64.4% to $890, stockholders' equity swung to a $(24,963) deficit from $4,301, and liabilities rose 21.5% to $256,157. Operating cash flows used $68,707, reflecting ongoing expenses including amortization of $34,214 and R&D of $5,500.

• ·Operating expenses totaled $31,820 for three months (including amortization $12,027, server rental $8,400, R&D $5,500) and $36,369 for nine months.
• ·Promissory note payable: $163,000 (down from $188,538); related party loan payable: $92,709 (up from $22,199).
• ·Accumulated deficit: $(68,388) as of February 28, 2026.
• ·No cash paid for interest or income taxes.

03-04-2026

The Kraft Heinz Company (KHC) has filed DEFA14A additional proxy materials for its 2026 Annual Meeting of Stockholders, scheduled virtually on May 14, 2026, at 11:00 a.m. ET. Key voting items include the election of 10 directors (all recommended FOR by the Board), an advisory vote to approve executive compensation (FOR), approval of the Amended and Restated 2020 Omnibus Incentive Plan (FOR), and ratification of PricewaterhouseCoopers LLP as independent auditors for 2026 (FOR). Proxy materials are available online via www.proxyvote.com or ir.kraftheinzcompany.com, with requests for paper/email copies due by April 30, 2026.

• ·Voting deadline: 11:59 p.m. ET on May 13, 2026 (May 11 for retirement plan shares)
• ·Virtual attendance: www.virtualshareholdermeeting.com/KHC2026
• ·Proxy voting site: www.proxyvote.com

03-04-2026

This DEF 14A proxy statement discloses executive officer biographies, including recent changes such as Dana E. Petitto as COO/Portfolio Manager, Theodore C. Hanno as CFO since January 2024, and K. Alexander Elawadi as CIO since December 2025; it also notes delinquent Section 16(a) filings by Elawadi and major Brookfield shareholders. Proposal No. 2 seeks stockholder ratification of Deloitte & Touche LLP as independent auditors for 2026, with audit fees increasing 11.6% YoY to $1,089,500 in 2025 from $976,400 in 2024 and no non-audit fees. Independent directors receive annual compensation of $125,000 ($145,000 for Audit Committee chair), split 50/50 cash and restricted stock.

• ·Delinquent Section 16(a) reports in FY 2025: K. Alexander Elawadi failed to timely file one Form 3; Brookfield Public Securities Group Holdings LLC (10% owner) failed one Form 3; Brookfield Oaktree Holdings Canada LLC (10% owner) failed one Form 3; Brookfield Asset Management Ltd. (10% owner) failed one Form 4.
• ·Company is externally managed with no direct employee compensation to executive officers; no pension, perquisites, or termination payments.
• ·No audit-related, tax, or other fees paid to Deloitte in 2025 or 2024.
• ·Restricted stock grants to directors vest after one year or earlier upon death, disability, non-renomination, or change in control.

03-04-2026

Cushman & Wakefield Ltd. (CWK) filed its 2026 DEF 14A Proxy Statement for the virtual Annual General Meeting on May 14, 2026, seeking approval to elect three independent director nominees (Jodie McLean, Timothy Wennes, and Billie Williamson), appoint KPMG LLP as independent auditor for the year ending December 31, 2026, conduct a non-binding advisory vote on Named Executive Officer compensation, and approve the 2026 Omnibus Share and Cash Incentive Plan. The company highlights its global platform with approximately 53,000 employees across over 350 offices in nearly 60 countries, managing 6.5 billion square feet of commercial real estate, and emphasizes its 'Better Never Settles' philosophy and strategic focus on growth areas like data centers. No declines or flat metrics are disclosed in the proxy.

• ·Record Date: March 16, 2026
• ·Annual Meeting location: Virtual webcast at meetnow.global/MTNRSGW
• ·Voting methods: Internet (www.envisionreports.com/CWK), phone (+1 800 652-8683), mail, or at virtual meeting
• ·2025 Annual Report on Form 10-K referenced and available online

03-04-2026

McCormick & Company, Incorporated held its Annual Meeting of Stockholders on April 1, 2026, electing eleven directors to its Board with strong support (For votes ranging 6,747,748 to 7,064,962; Against 227,029 to 563,674). Stockholders ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending November 30, 2026 (11,535,004 For; 78,347 Against), and approved Named Executive Officers' compensation in an advisory vote (6,948,728 For; 280,800 Against). All proposals passed with overwhelming majorities and consistent broker non-votes of 4,310,449.

• ·Auditor ratification: 11,535,004 For, 78,347 Against, 78,054 Abstain
• ·Executive compensation approval: 6,948,728 For, 280,800 Against, 151,428 Abstain

03-04-2026

Benchmark 2019-B14 Mortgage Trust filed an 8-K announcing that the special servicer for The Essex Mortgage Loan, constituting approximately 4.3% of the asset pool as of the cut-off date, was changed from Midland Loan Services (a Division of PNC Bank, National Association) to KeyBank National Association, effective April 3, 2026, pursuant to Section 7.01(d) of the BMARK 2019-B14 PSA dated November 1, 2019. This procedural change is in the interest of transaction management with no reported impact on performance metrics.

• ·KeyBank principal servicing offices located at 11501 Outlook Street, Suite 300, Overland Park, Kansas 66211.
• ·Pooling and servicing agreement originally filed as Exhibit 4.1 to Form 8-K/A on December 17, 2019.

03-04-2026

Pinnacle West Capital Corp (PNW) filed a DEFA14A Definitive Additional Proxy Materials on April 03, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is by the registrant with no fee required. No substantive proxy details, financial data, or voting matters are included in the provided header content.

03-04-2026

Chicago Rivet & Machine Co. has issued a proxy statement for its Annual Meeting of Shareholders on May 12, 2026, to elect seven director nominees, including CEO Gregory D. Rizzo and non-executive Chairman James W. Morrissey, with the board being 86% independent and 71% refreshed over the last five years. As of the record date March 13, 2026, 966,132 shares of common stock were outstanding. Principal shareholders owning more than 5% include John A. Morrissey (10.35%), Walter W. Morrissey Trust (8.7%), Dimensional Fund Advisors LP (6.5%), and Galloway Capital Partners, LLC (6.45%); management and directors as a group beneficially own 5,088 shares (<1%).

• ·Annual Meeting location: Sheraton Lisle Hotel, 3000 Warrenville Road, Lisle, Illinois, 60532, at 10:00 AM CDT.
• ·Proxy materials first mailed on or about April 2, 2026.
• ·Voting: Cumulative voting for directors; majority of shares represented required for approval.
• ·Ratification of Cherry Bekaert LLP as independent auditors for 2026.
• ·Board tenure: 3 directors <5 years, 2 between 5-10 years, 2 >10 years.

03-04-2026

CFCRE 2016-C7 Mortgage Trust announced via 8-K that Situs Holdings, LLC was removed as special servicer for the Potomac Mills Mortgage Loan, which represents approximately 6.2% of the asset pool as of the cut-off date, and Torchlight Loan Services, LLC was appointed as successor special servicer effective April 3, 2026, under the CFCRE 2016-C6 PSA. This change is in the interest of transaction management with no disclosed financial impacts or performance metrics. The filing provides Torchlight's contact details for special servicing.

• ·Pooling and Servicing Agreement (PSA) dated November 1, 2016
• ·Torchlight principal office: 90 Park Avenue, 20th Floor, New York, New York 10016; Phone: 212-883-2800

03-04-2026

Wells Fargo Commercial Mortgage Trust 2016-C37 filed an 8-K announcing that the Potomac Mills Mortgage Loan, comprising approximately 4.8% of the asset pool as of its cut-off date, will now be specially serviced by Torchlight Loan Services, LLC, replacing Situs Holdings, LLC, effective April 3, 2026, under the CFCRE 2016-C6 PSA. This administrative change is made in the interest of transaction management. No performance metrics or financial impacts were disclosed.

• ·CFCRE 2016-C6 PSA dated as of November 1, 2016
• ·Torchlight principal special servicing office: 90 Park Avenue, 20th Floor, New York, New York 10016; Telephone: 212-883-2800

03-04-2026

Bank of America Merrill Lynch Commercial Mortgage Trust 2017-BNK3 announced that Situs Holdings, LLC has been removed as special servicer for the Potomac Mills Mortgage Loan, which represents approximately 2.1% of the asset pool as of the cut-off date, and Torchlight Loan Services, LLC has been appointed as the successor special servicer effective April 3, 2026, under the CFCRE 2016-C6 PSA. This change is in the interest of transaction management. No performance metrics or financial impacts were disclosed.

• ·Torchlight Loan Services, LLC principal office: 90 Park Avenue, 20th Floor, New York, New York 10016; telephone: 212-883-2800
• ·Servicing governed by pooling and servicing agreement dated November 1, 2016

03-04-2026

The COMM 2019-GC44 Mortgage Trust filed an 8-K announcing that Midland Loan Services has been removed as special servicer for The Essex Site 2 Mortgage Loan, which represents approximately 3.4% of the asset pool as of the cut-off date, with KeyBank National Association appointed as successor special servicer effective April 3, 2026. This loan is part of a combination serviced under the Benchmark 2019-B14 Mortgage Trust's pooling and servicing agreement. No financial performance metrics or changes were disclosed.

• ·Servicing governed by pooling and servicing agreement dated November 1, 2019.
• ·KeyBank principal servicing offices: 11501 Outlook Street, Suite 300, Overland Park, Kansas 66211.
• ·Filing signed on behalf of Deutsche Mortgage & Asset Receiving Corporation.

03-04-2026

The Potomac Mills Mortgage Loan, constituting approximately 5.7% of the asset pool as of the cut-off date in the Morgan Stanley Bank of America Merrill Lynch Trust 2016-C32, has undergone a change in special servicer. Situs Holdings, LLC was removed, and Torchlight Loan Services, LLC was appointed as successor special servicer effective April 3, 2026, pursuant to Section 3.22(i) of the CFCRE 2016-C6 PSA. This update is filed in the interest of transaction management.

• ·Torchlight Loan Services, LLC principal special servicing office: 90 Park Avenue, 20th Floor, New York, New York 10016; Telephone: 212-883-2800
• ·Pooling and servicing agreement dated November 1, 2016

03-04-2026

Citigroup Commercial Mortgage Trust 2016-P6 reported a change in the special servicer for the Potomac Mills mortgage loan under the CFCRE 2016-C6 PSA. Situs Holdings, LLC was terminated as special servicer effective April 3, 2025, and Torchlight Loan Services, LLC was appointed as successor special servicer effective April 3, 2026. The Acknowledgment of Replacement Special Servicer dated April 3, 2026, is attached as Exhibit 20.1.

• ·Filing date: April 3, 2026
• ·Date of earliest event: April 3, 2026
• ·Pool and servicing agreement dated November 1, 2016, filed as Exhibit 4.5 to 8-K on December 15, 2016

03-04-2026

Citigroup Commercial Mortgage Trust 2016-C3 reported a change in the special servicer for the Potomac Mills mortgage loan under the CFCRE 2016-C6 PSA. Effective April 3, 2025, Situs Holdings, LLC was terminated as special servicer, and Torchlight Loan Services, LLC was appointed as successor special servicer. The acknowledgment of this replacement, dated April 3, 2026, is attached as Exhibit 20.1.

• ·Filing date: April 3, 2026
• ·Date of earliest event: April 3, 2026
• ·Effective date of servicer change: April 3, 2025
• ·Issuing entity CIK: 0001687605
• ·Depositor CIK: 0001258361

03-04-2026

Toyota Motor Credit Corporation announced the retirement of Scott Cooke as President, Chief Executive Officer, and Chairman of the Board effective April 6, 2026, after which he will serve as Executive Advisor to Toyota Financial Services Corporation's Americas Oceania Region until June 30, 2026. Alec Hagey, currently an executive advisor and previously Senior Vice President and Chief Operating Officer, has been appointed as Cooke's successor in those roles effective the same date and is expected to also serve as President and Chief Operating Officer of parent Toyota Financial Services International Corporation. The changes were detailed in a press release furnished as Exhibit 99.1.

• ·Event reported date: March 30, 2026
• ·Filing date: April 3, 2026
• ·Biographical details available in Form 10-K for fiscal year ended March 31, 2025, filed June 3, 2025
• ·Alec Hagey joined Toyota in 1990

03-04-2026

The Benchmark 2019-B15 Mortgage Trust announced that, effective April 3, 2026, Midland Loan Services, a Division of PNC Bank, National Association, has been terminated as special servicer for The Essex loan combination under the BMARK 2019-B14 PSA, with KeyBank National Association appointed as successor special servicer. This change pertains to the servicing of the Essex mortgage loan, an asset of the trust. An Acknowledgment of Replacement Special Servicer dated April 3, 2026, is attached as Exhibit 20.1.

• ·The BMARK 2019-B14 PSA was filed as Exhibit 4.3 to the registrant's Current Report on Form 8-K dated December 18, 2019.
• ·The pooling and servicing agreement for the Issuing Entity was filed as Exhibit 4.1 to the Current Report on Form 8-K dated December 18, 2019.

03-04-2026

Hickory Point Bank & Trust filed its 13F-HR report on April 3, 2026, disclosing institutional equity holdings as of March 31, 2026, across 585 positions with a total portfolio market value of $151521193000. The portfolio features diversified large-cap U.S. stocks including Abbott Laboratories, AbbVie, Apple, Alphabet, Amazon, and Bank of America. No period-over-period changes are disclosed in this filing.

• ·Filing CIK: 0002039144
• ·Report period end: 2026-03-31

03-04-2026

On March 30, 2026, Intel Corporation announced that April Miller Boise, its Executive Vice President and Chief Legal Officer, will separate from the company effective June 1, 2026. Ms. Miller Boise will receive severance benefits under the Intel Corporation Executive Severance Plan in exchange for a release of claims. The Form 8-K was filed on April 3, 2026, and signed by David Zinsner, Executive Vice President and Chief Financial Officer.

• ·Date of earliest event reported: March 30, 2026
• ·Items reported: 5.02 (Departure of Directors or Certain Officers) and 9.01 (Financial Statements and Exhibits)

03-04-2026

Moog Inc. fully redeemed its $500 million aggregate principal amount of 4.250% Senior Notes due 2027 on April 3, 2026, at 100.000% of the principal plus accrued and unpaid interest. The redemption was funded using net proceeds from a new $500 million aggregate principal amount offering of 5.500% Senior Notes due 2034 and available cash on hand. The related indenture, dated December 13, 2019, with U.S. Bank Trust Company, National Association as trustee, has been satisfied and discharged.

• ·Redemption price equal to 100.000% of principal amount plus accrued and unpaid interest to, but not including, April 3, 2026.
• ·Indenture dated December 13, 2019.

03-04-2026

Deluxe Corporation filed Amendment No. 1 to its proxy statement for the 2026 Annual Meeting on April 3, 2026, updating stock ownership, NEO identification, and executive compensation disclosures to correct prior errors. FY2025 performance showed mixed results with total revenue of $2.133B, strong growth in Data Solutions (+31.3% to $307.3M) and Merchant Services (+3.8% to $398.6M), modest B2B Payments growth (+0.9% to $290.5M), but Print segment decline (-5.7% to $1.137B); adjusted EBITDA reached $431.5M and adjusted EPS $3.61. The amendment confirms no delinquent Section 16(a) reports and highlights progress under the completed North Star program.

• ·Annual Meeting date: April 23, 2026; Record date: February 23, 2026
• ·Closing stock price as of December 31, 2025: $22.33
• ·All Section 16(a) reports filed timely in 2025
• ·Amendment corrects NEOs and deferred compensation earnings in Summary Compensation Table

03-04-2026

Future Money Acquisition Corporation consummated its initial public offering (IPO) on March 30, 2026, selling 11,200,000 units at $10.00 per unit, generating gross proceeds of $112,000,000. Simultaneously, the company completed a private placement of 304,000 units to sponsor Future Wealth Capital Corp. at $10.00 per unit for $3,040,000 in gross proceeds. A total of $112,560,000 from both was placed in a trust account, after offsetting a $290,855 sponsor loan, with an audited balance sheet issued as Exhibit 99.1.

• ·Units consist of one ordinary share (par value $0.0001) and one right entitling holder to one-fifth of one ordinary share upon initial business combination.
• ·Trading symbols: FMACU (Units), FMAC (Ordinary Shares), FMACR (Rights) on Nasdaq.
• ·Audited balance sheet as of March 30, 2026, included as Exhibit 99.1.

03-04-2026

KORU Medical Systems, Inc. entered into Amendment No. 3 to its Loan and Security Agreement with HSBC Ventures USA Inc., effective March 30, 2026, extending the Revolving Line Maturity Date to March 30, 2028, Term Loan Maturity Date to December 1, 2029, and Draw Period End Date to June 30, 2027, with potential further extensions upon achieving the EBITDA Milestone Event of positive Adjusted EBITDA for two consecutive fiscal quarters by June 30, 2027. Interest rates were adjusted to the greater of Prime Rate (or Prime minus 0.50% for Term Loans) or 5.50%, and the financial covenant shifted to Remaining Months Liquidity greater than 12, replacing the prior Adjusted Quick Ratio, while requiring at least $5,000,000 in unrestricted cash with the Bank. No declines or flat metrics are present in this amendment, which provides extended financing flexibility conditional on performance.

• ·Eligible Foreign Accounts limited to Account Debtors in Approved Countries: Canada, France, Germany, Italy, Japan, United Kingdom.
• ·Term Loan Amortization Date: July 1, 2027, extendable to January 1, 2028 upon EBITDA Milestone Event.
• ·Repayment Schedule: 30 months, reducible to 24 months upon EBITDA Milestone Event.
• ·Financial covenant tested monthly after Testing Event (initial Advance), with exception if trailing three-month average Adjusted EBITDA is positive.

03-04-2026

NewtekOne, Inc. renewed one-year employment agreements effective April 1, 2026, with executives Barry Sloane (CEO and President), Michael A. Schwartz (Chief Legal Officer and Corporate Secretary), and Frank DeMaria (Chief Financial Officer and Executive Vice President), with terms unchanged except for added non-renewal payments equal to one year of base compensation in some agreements. The Company's subsidiary, Newtek Bank, N.A., similarly renewed the employment agreement with President Peter Downs on identical terms. These renewals ensure executive continuity with no reported changes to compensation structures beyond the non-renewal provision.

• ·Renewals filed under Item 5.02 of Form 8-K on April 3, 2026.
• ·Employment agreements to be filed as exhibits in next Quarterly Report on Form 10-Q.
• ·Change in Control Agreements remain unchanged from Form 10-K for year ended December 31, 2024.

03-04-2026

American Rebel Holdings Inc. filed an S-1 registration statement on April 3, 2026, for an initial public offering amid numerous risks including debt obligations, Nasdaq listing compliance, material weaknesses in internal controls, litigation, supply chain disruptions, and dilution from financing. Recent positive developments include minority acquisitions such as 19.01% interest in Schmitty’s for approximately $1.99 million, RAEK Data interests totaling $2.5 million, initial 30% in 218 3rd Avenue entity for a $14.1 million building via stock and promissory note, and a $2 million portion of Damon Note. These strategic moves aim to expand into smokeless products, real estate, and licensing, but face execution risks and no guaranteed revenue impact.

• ·Schmitty’s acquisition includes 11 common shares and prefunded warrants for 30 shares at $0.01.
• ·218 3rd Avenue payments structured in $100,000 cash installments for 1% each and note conversions for 1% per $1.5M tranche.
• ·Damon Note secured pari passu with Streeterville; Company cannot pursue collections without consent.
• ·New subsidiary American Rebel Licensing NIL I, Inc. formed in February 2026 for licensing opportunities.

03-04-2026

Climb Bio, Inc. announced on April 1, 2026, the mutual separation of Cindy Driscoll, its Senior Vice President, Finance and principal accounting officer, effective April 30, 2026. Dr. Susan Altschuller, the Company's Chief Financial Officer since October 2025, will also serve as principal accounting officer effective the same date, with no changes to her compensatory arrangements. The change maintains continuity in financial leadership, as Dr. Altschuller has prior CFO experience at Dragonfly Therapeutics, Cerevel Therapeutics (acquired by AbbVie), and ImmunoGen.

• ·Dr. Altschuller, age 44, holds a BSE in Biomedical Engineering from Tulane University, a Ph.D. in biomedical engineering from the Illinois Institute of Technology, and an MBA from MIT Sloan.
• ·Dr. Altschuller has no family relationship with any Company officers or directors and no disclosable interests under Item 404(a) of Regulation S-K.
• ·The Form 8-K was filed on April 3, 2026.

03-04-2026

BlackRock, Inc. ('New BlackRock') and BlackRock Finance, Inc. entered into Amendment No. 17 to their Five-Year Revolving Credit Agreement originally dated March 10, 2011, effective as of March 31, 2026, to extend the Maturity Date pursuant to Section 2.10 and make other amendments including commitment adjustments and joining lenders. The amendment replaces Schedules 1.1(b) (Commitments) and 1.1(c) (Extending/Non-Extending Lenders), with reallocations among lenders effective on the Amendment No. 17 Effective Date. No specific financial amounts or negative impacts are disclosed in the filing.

• ·Original Credit Agreement dated March 10, 2011, with 16 prior amendments listed from 2012 to 2025.
• ·Amendment requires execution by Borrowers, Guarantors, all Lenders, Swingline Lenders, and Issuing Lenders for effectiveness.
• ·No Default or Event of Default existing as represented by Borrowers.

03-04-2026

Velo3D, Inc. filed an S-3 shelf registration statement on April 3, 2026, enabling the potential offering of up to $500,000,000 in common stock (par value $0.00001), preferred stock (par value $0.00001), debt securities, warrants, and units over time via prospectus supplements. The company notes its status as a smaller reporting company with less than $100 million in annual revenue, reducing certain disclosure obligations. The filing incorporates the FY 2025 10-K and recent 8-Ks, emphasizing high investment risks and forward-looking statement cautions.

• ·Common stock par value: $0.00001 per share
• ·Preferred stock par value: $0.00001 per share
• ·Incorporates Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed March 31, 2026
• ·Incorporates Current Reports on Form 8-K filed February 20, 2026, March 6, 2026, and March 24, 2026 (excluding Item 2.02 information)
• ·Company address: 2710 Lakeview Court, Fremont, California 94538

03-04-2026

Rigel Pharmaceuticals, Inc. (RIGL) has filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on May 14, 2026 (virtual), with record date March 19, 2026, seeking election of three director nominees (Alison Hannah, M.D., Walter Moos, Ph.D., and Raul Rodriguez) for terms until 2029. Shareholders are asked to approve amendments adding 500,000 shares to the 2018 Equity Incentive Plan and 360,000 shares to the 2000 Employee Stock Purchase Plan, along with an advisory vote on NEO compensation and ratification of Ernst & Young LLP as auditors for FY 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Annual Meeting date and time: May 14, 2026 at 7:30 a.m. Pacific Daylight Time (virtual at www.virtualshareholdermeeting.com/RIGL2026)
• ·Record date: March 19, 2026
• ·Filing date: April 03, 2026